Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)
All News about Ensysce Biosciences, Inc. - Common Stock
Via ACCESSWIRE
Ensysce Biosciences Reports Third Quarter 2023 Financial Results
November 09, 2023
Via ACCESSWIRE
Ensysce Biosciences Secures $1.7 Million Convertible Note Financing
October 24, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Completes Scale Up Manufacture of PF614 to Support Phase 3 Studies
September 14, 2023
Via ACCESSWIRE
Ensysce Presents "A New Generation of Safer Pain Treatments"
September 07, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Announces IRB Approval of Key Study Protocol
August 08, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 05, 2023
Via ACCESSWIRE
Ensysce Biosciences Regains Compliance with Nasdaq
June 13, 2023
Via ACCESSWIRE